ESMO: Combination therapy reduced agitated delirium in patients with advanced cancers Dr. Kamal Kant Kohli24 Sept 2024 2:30 AM ISTTreatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with...
ESMO updates guidelines on cancer Adrenal gland Dr. Kamal Kant Kohli30 Sept 2020 6:00 PM ISTEuropean Society for Medical Oncology (ESMO) has released its updated Clinical Practice Guidelines on cancer adrenal gland. Two different primary...
ESMO releases Guideline on the management of cancer-related fatigue Dr. Kamal Kant Kohli30 March 2020 6:00 PM ISTEuropean Society for Medical Oncology has released an update on the ESMO Clinical Practice Guideline on the management of cancer-related fatigue...
Management of marginal zone lymphomas-Updated ESMO guidelines Dr. Kamal Kant Kohli28 Jan 2020 3:06 PM ISTMarginal zone lymphomas represent approximately 5%–15% of all non-Hodgkin lymphomas in the Western world. EMZLs comprise approximately two-thirds and...
